中华麻醉学杂志
中華痳醉學雜誌
중화마취학잡지
CHINESE JOURNAL OF ANESTHESIOLOGY
2013年
3期
286-288
,共3页
张辉%张稳稳%赵伟%邵雅洁%颜明%刘功俭
張輝%張穩穩%趙偉%邵雅潔%顏明%劉功儉
장휘%장은은%조위%소아길%안명%류공검
骨肿瘤%疼痛%细胞外信号调节MAP激酶类%脊髓
骨腫瘤%疼痛%細胞外信號調節MAP激酶類%脊髓
골종류%동통%세포외신호조절MAP격매류%척수
Bone neoplasms%Pain%Extracellular signal-regulated MAP kinases%Spinal cord
目的 评价胫骨癌痛大鼠脊髓细胞外信号调节激酶5(ERK5)活性的变化.方法 雌性未交配SD大鼠108只,体重160~ 180 9,采用随机数字表法,将其分为3组(n=36):对照组(C组)、假手术组(S组)和胫骨癌痛组(BCP组).BCP组胫骨骨髓腔内注射Walker256乳腺癌细胞混悬液制备大鼠胫骨癌痛模型;S组胫骨骨髓腔内注射等容量生理盐水;C组不作任何处理.于接种前1d、接种后3、5、7、14和21 d时,测定机械痛阈.C组和S组于接种后21 d痛阈测定结束后随机处死6只大鼠,BCP组分别于接种后3、5、7、14和21 d痛阈测定结束后随机处死6只大鼠,取脊髓组织,采用Westernblot法测定脊髓背角磷酸化ERK5(p-ERK5)、ERK5和Fos蛋白的表达.结果 C组和S组各时点机械痛阈、脊髓背角p-ERK5、ERK5和Fos蛋白的表达差异无统计学意义(P>0.05).与C组和S组比较,BCP组接种后7-21 d时机械痛阈下降,接种后5-21 d时脊髓p-ERK5和Fos蛋白表达上调(P<0.05),ERK5表达差异无统计学意义(P>0.05).结论 大鼠胫骨骨髓腔内注射肿瘤细胞可能通过增强脊髓ERK5活性,导致其下游Fos蛋白的释放,从而诱发骨癌痛.
目的 評價脛骨癌痛大鼠脊髓細胞外信號調節激酶5(ERK5)活性的變化.方法 雌性未交配SD大鼠108隻,體重160~ 180 9,採用隨機數字錶法,將其分為3組(n=36):對照組(C組)、假手術組(S組)和脛骨癌痛組(BCP組).BCP組脛骨骨髓腔內註射Walker256乳腺癌細胞混懸液製備大鼠脛骨癌痛模型;S組脛骨骨髓腔內註射等容量生理鹽水;C組不作任何處理.于接種前1d、接種後3、5、7、14和21 d時,測定機械痛閾.C組和S組于接種後21 d痛閾測定結束後隨機處死6隻大鼠,BCP組分彆于接種後3、5、7、14和21 d痛閾測定結束後隨機處死6隻大鼠,取脊髓組織,採用Westernblot法測定脊髓揹角燐痠化ERK5(p-ERK5)、ERK5和Fos蛋白的錶達.結果 C組和S組各時點機械痛閾、脊髓揹角p-ERK5、ERK5和Fos蛋白的錶達差異無統計學意義(P>0.05).與C組和S組比較,BCP組接種後7-21 d時機械痛閾下降,接種後5-21 d時脊髓p-ERK5和Fos蛋白錶達上調(P<0.05),ERK5錶達差異無統計學意義(P>0.05).結論 大鼠脛骨骨髓腔內註射腫瘤細胞可能通過增彊脊髓ERK5活性,導緻其下遊Fos蛋白的釋放,從而誘髮骨癌痛.
목적 평개경골암통대서척수세포외신호조절격매5(ERK5)활성적변화.방법 자성미교배SD대서108지,체중160~ 180 9,채용수궤수자표법,장기분위3조(n=36):대조조(C조)、가수술조(S조)화경골암통조(BCP조).BCP조경골골수강내주사Walker256유선암세포혼현액제비대서경골암통모형;S조경골골수강내주사등용량생리염수;C조불작임하처리.우접충전1d、접충후3、5、7、14화21 d시,측정궤계통역.C조화S조우접충후21 d통역측정결속후수궤처사6지대서,BCP조분별우접충후3、5、7、14화21 d통역측정결속후수궤처사6지대서,취척수조직,채용Westernblot법측정척수배각린산화ERK5(p-ERK5)、ERK5화Fos단백적표체.결과 C조화S조각시점궤계통역、척수배각p-ERK5、ERK5화Fos단백적표체차이무통계학의의(P>0.05).여C조화S조비교,BCP조접충후7-21 d시궤계통역하강,접충후5-21 d시척수p-ERK5화Fos단백표체상조(P<0.05),ERK5표체차이무통계학의의(P>0.05).결론 대서경골골수강내주사종류세포가능통과증강척수ERK5활성,도치기하유Fos단백적석방,종이유발골암통.
Objective To evaluate the changes in the activity of extracellular signal-regulated protein kinase 5 (ERK5) in the spinal cord in a rat model of bone cancer pain (BCP).Methods One hundred and eight female Sprague-Dawley rats,weighing 160-180 g,were randomly divided into 3 groups (n =36 each):control group (group C):sham operation (group S) and group BCP.In group BCP Walker 256 mammary gland cancer cell suspension (1 × 105 cells/ml) 5 μl was injected into the left tibia,while in group S normal saline 5μl was injected into the left tibia instead of cancer cell suspension.Group C underwent no treatment.Mechanical paw withdrawal threshold to von Frey filament stimulation (MWT) was measured at 1 day before inoculation and 3,5,7,14 and 21 days after inoculation.Six rats were sacrificed after the last measurement of MWT in groups C and S or after measurement of MWT at 3,5,7,14 and 21 days after inoculation in group BCP and the spinal cord was removed for determination of the expression of phosphorylated ERK5 (p-ERK5),ERK5 and Fos protein in the spinal dorsal horn by Western blot analysis.Results There was no significant difference in the MWT and expression of p-ERK5,ERK5 and Fos protein at each time point between groups C and S (P > 0.05).Compared with groups C and S,MWT was significantly decreased at 7-21 days after inoculation,the expression of p-ERK5 and Fos protein was significantly up-regulated at 5-21 days after inoculation (P < 0.05),and no significant change was found in the expression of ERK5 in group BCP (P > 0.05).Conclusion Intra-tibial inoculation of Walker-256 breast cancer cells can increase the activity of ERK5 in the spinal cord in rats,leading to the increased release of Fos protein,thus inducing BCP.